Article Details
Retrieved on: 2018-03-04 19:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Additionally, shares of ITUS, which develops, acquires, and licenses <b>emerging</b> <b>technologies</b> in the areas of biotechnology, have a Relative Strength Index (RSI) of 50.14. On February 07<sup>th</sup>, 2018, ITUS announced that its presentation titled "The coupling of MDSCs with a computational analytic method to ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here